Please login to the form below

Not currently logged in
Email:
Password:

Tabalumab

This page shows the latest Tabalumab news and features for those working in and with pharma, biotech and healthcare.

Lilly reports first pivotal data for Xeljanz rival in arthritis

Lilly reports first pivotal data for Xeljanz rival in arthritis

Meanwhile, the positive data for baricitinib in RA is a boost for Lilly's anti-inflammatory portfolio, which suffered a casualty in October when tabalumab was dropped from development.

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
...
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics